ERJ Podcast July 2025: Implementation of European national driving regulations for OSA
ERS Publications PodcastsShow Notes
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Walter McNicholas (School of Medicine and the Conway Research Institute, University College Dublin, and Department of Respiratory and Sleep Medicine, St Vincent’s Hospital Group, Dublin, Ireland) about the challenges of implementing European national driving regulations for obstructive sleep apnoea, as discussed in Prof. McNicholas’ article in this issue of the ERJ: https://doi.org/10.1183/13993003.02484-2024
Cite this podcast as: ERJ Podcast July 2025: Implementation of European national driving regulations for OSA. Eur Respir J 2025; 66: 25E6601 [https://doi.org/10.1183/13993003.E6601-2025].
More from ERS Publications Podcasts
"We [should] not only focus on one treatment option but we should discuss how we can combine different options; this has to be studied in more detail"
As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews editorial board member Christina Thornton and associate editor Marcus Mall about their Back to Basics review article on bridging the airway microbiome and targeted therapy in bronchiectasis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.00239-2026).
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, The Netherlands) about her multicentre randomised crossover trial of fentanyl and morphine for persistent dyspnoea in COPD, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01431-2025).
As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marlies Wijsenbeek about data from the whole follow-up period of the FIBRONEER-ILD trial of nerandomilast in progressive pulmonary fibrosis, published in this issue of the ERJ (https://doi.org/10.1183/13993003.01272-2025).
"Making ultrasound as widespread and as used as the stethoscope... that's the big challenge going forwards"